Disclosed is a method of directing a cellular immune response against an HIV-infected cell in a mammal involving administering to the mammal an effective amount of therapeutic cells which express a membrane-bound, proteinaceous chimeric receptor comprising (a) an extracellular portion which includes a fragment of CD4 which is capable of specifically recognizing and binding the HIV-infected cell but which does not mediate HIV infection and (b) an intracellular portion which is capable of signalling the therapeutic cell to destroy the receptor-bound HIV-infected cell. Also disclosed are cells which express the chimeric receptors and DNA and vectors encoding the chimeric receptors.

 
Web www.patentalert.com

< Methods and compositions for detecting larval Taenia solium with a cloned diagnostic antigen

< Bacillus sp. D747 strain, plant disease controlling agents and insect pest controlling agents using the same and control method using the agents

> Formation of polyampholytes in the presence of a polyion

> Pharmaceutical composition for boron neutron capture therapy containing triphenylboroxin

~ 00284